Skip to content

Download Library

Download Library

Date Title Documents

Vaxart Provides Merger Update

VaxartAnnouncesReducedInfluenzaInPhase2InfluenzaChallenge013118.pdf

Vaxart, Inc. Closes Merger with Aviragen Therapeutics, Inc.

Proxy Statement

Proxy Card - Front

Proxy Card - Back

Audit Committe Charter

Code of Conduct

Corporate Governance Principles

2016 Annual Report

Log In

Create an account